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The mechanism of genome packaging in adenoviruses (AdVs) is presumed to be similar
to that of dsDNA viruses including herpesviruses and dsDNA phages. First, the empty
capsids are assembled after which the viral genome is pushed through a unique vertex
by a motor which consists of three minimal components: an ATPase, a small terminase
and a portal. Various components of this motor exist as ring-like structures forming
a central channel through which the DNA travels during packaging. In AdV, the IVa2
protein is believed to function as a packaging ATPase, however, the equivalents of the
small terminase and the portal have not been identified in AdVs. IVa2 interacts with
another viral protein late region 4 (L4) 33K which is important for genome packaging.
Both IVa2 and 33K are expressed at high levels during the late stage of virus infection.
The oligomeric state of IVa2 and 33K was analyzed in virus-infected cells, IVa2 and
33K transfected cells, AdV particles, or as recombinant purified proteins. Electron
microscopy of the purified proteins showed ring-like oligomers for both proteins which
is consistent with their putative roles as a part of the packaging motor. We found that
the ATPase activity of IVa2 is stimulated in the presence of 33K and the AdV genome.
Our results suggest that the 33K functions analogous to the small terminase proteins
and so will be part of the packaging motor complex.
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Introduction
Adenoviruses (AdVs) are non-enveloped icosahedral viruses with a linear dsDNA genome ranging
in size from 28 to 45 kbp. The AdV genomes carry conserved AT-rich repeat regions, named ‘A-
repeats,’ located between the left inverted terminal repeat (ITR) and the transcriptional start site of
early region (E) 1 (E1) in the viral genome (Kosturko et al., 1982; Ostapchuk and Hearing, 2003a,b,
2005; Xing and Tikoo, 2003, 2007). This set of A-repeats constitutes the packaging domain (PD)
of an AdV genome. The PD of the human AdV serotype 5 (HAdV5) genome is located between
nucleotides 220–400 and consists of seven A-repeats numbered from A1 through A7 (Ostapchuk
and Hearing, 2005).
IVa2 is expressed from the early region (E) 2b region located on the minus strand of the viral
genome (Binger and Flint, 1984) and contains nuclear as well as nucleolar localization signals
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(Lutz et al., 1996). Initially, IVa2 was identiﬁed as a component
of two protein complexes that associate with downstream ele-
ments (DEs), DE1 and DE2, of the major late promoter (Lutz
and Kedinger, 1996). The homology between sequences of the PD
and DE led to the discovery of the role of IVa2 in genome pack-
aging (Zhang and Imperiale, 2000). The binding of IVa2 to the A
repeats of the PD is required for the packaging of the viral genome
(Zhang and Imperiale, 2000; Zhang et al., 2001; Ostapchuk et al.,
2005). IVa2 is also required for recruiting the viral protein L4 22K,
an important packaging factor, to the PD (Ostapchuk et al., 2006;
Ewing et al., 2007; Tyler et al., 2007). IVa2 is present in equal
amounts in all forms of AdV assembly intermediates including
the empty capsids, light intermediate particles, young virions and
mature virions (Winter and D’Halluin, 1991). Sequence analysis
of IVa2 showed the presence of Walker A and Walker B motifs,
a characteristic feature of all ATPases. Furthermore, IVa2 has
been shown to bind ATP, suggesting that it could function as
an ATPase (Ostapchuk and Hearing, 2008). IVa2 mutants car-
rying mutations in Walker A and Walker B motifs, or lacking
a C-terminal fragment encompassing these motifs, resulted in
an accumulation of empty capsids implying a defect in genome
packaging. Collectively, these results imply that IVa2 is similar
to the DNA packaging ATPases observed in dsDNA phages and
herpesviruses (Rao and Feiss, 2008; Ostapchuk et al., 2011). It is
a common theme in dsDNA phages and herpesviruses that the
genome packaging complex or the proteins involved in genome
packaging assemble at a unique vertex (Rao and Feiss, 2008). IVa2
has been shown to be located at a unique vertex of mature virions
with only 6–8 copies per capsid again suggesting its role as a DNA
packaging ATPase (Christensen et al., 2008; Ahi et al., 2013).
The 33K protein of HAdV5 contains 229 amino acid residues
and has been identiﬁed as a nuclear phosphoprotein found in
the infected cell nucleus as a unique granular structure (Gambke
and Deppert, 1981). 33K is expressed from the late region 4
(L4) of the major late transcription unit and is a 25 kDa molec-
ular mass, as predicted by its amino acid sequence, but runs
anomalously at 35 kDa. 33K is detected in empty capsids but
not in mature virions, suggesting that it may be required as
a scaﬀolding protein for capsid assembly (Ahi et al., 2013). A
truncated 33K lacking the C-terminal 47 amino acids fails to
assemble capsids (Finnen et al., 2001). Similar results were also
seen with C-terminal truncation of the 33K protein of bovine
adenovirus serotype 3 (BAdV3). Truncation of the BAdV3 33K
after the 97th amino acid completely abolished capsid assembly
(Kulshreshtha et al., 2004). However, when a stop codon was
introduced at 7th or 20th position in the ORFs of 33K in the
BAdV3 or HAdV5 genome, respectively, capsid assembly was not
aﬀected, but the virus yield was reduced by several fold, indi-
cating that the defect may be at the level of genome packaging
(Fessler and Young, 1999; Kulshreshtha et al., 2004). In support
of this role as a packaging factor, 33K was shown to interact
with IVa2 and localize at a single site on viral capsids (Ahi et al.,
2013).
In order to further understand the roles of IVa2 and 33K dur-
ing genome packaging, we evaluated the oligomeric state of IVa2
and 33K in AdV-infected cells, IVa2 and 33K transfected cells,
puriﬁed virions or in puriﬁed protein preparations and provide
the ﬁrst evidence of ATPase activity of IVa2 in the presence of
33K and the AdV genome.
Materials and Methods
Cell Lines, Viruses, and Plasmids
The 293 cell line was derived from the human embryonic kid-
ney cells by transformation with the E1 region of HAdV5
(Graham et al., 1977). The 293cre cell line is derived from
293 cells and constitutively expresses cre recombinase (Parks
et al., 1996). 293-IVa2 cells are 293 cells constitutively express-
ing the HAdV5 IVa2 protein (Ahi et al., 2013). 293-33K cells
are generated by stable transfection of 293 cells with pcDNA-
33K. These cell lines were maintained in minimum essen-
tial medium (MEM) with 10% FetalClone III (Thermo Fisher
Scientiﬁc Inc., Waltham, MA, USA) and gentamicin (50 μg
ml−1). Preparation of virus stocks and puriﬁcation of HAdV5
and ADLC8luc (Parks et al., 1996) was done as described ear-
lier (Graham and Prevec, 1991). Brieﬂy, 293 or 293cre cells were
infected, respectively, with HAdV5 or ADLC8luc at a multi-
plicity of infection (m.o.i.) of 5 plaque-forming units (PFUs)
per cell. At 48 h following infection, complete cytopathic eﬀect
(CPE) was observed, the infected cells were harvested, and the
cell pellet was collected after centrifugation at 3,000 rpm. at
4◦C for 10 min. For preparation of the virus stock, the infected
cell pellet was re-suspended in PBS2+ (Phosphate buﬀered
saline, pH7.4, containing 0.01% MgCl2, CaCl2) plus 10% glyc-
erol. Viruses were released from infected cells by three cycles
of freeze-thaw, and the cell lysates were stored at −80◦C.
For virus puriﬁcation, the virus was similarly grown, and the
infected cell pellet was processed for virus puriﬁcation by cesium
chloride density-gradient centrifugation (Graham and Prevec,
1991). Virus titers were achieved by plaque assay in BHH2C
(bovine-human hybrid clone 2C) cells (van Olphen and Mittal,
2002).
Escherichia coli expression plasmids pET28-IVa2 and pET28-
33K were created by cloning the synthetic IVa2 or 33K gene
cassette (codon-optimized for bacterial expression), respectively,
into the pET28a plasmid (EMD Biosciences, San Diego, CA,
USA). The pcDNA-IVa2 (Ahi et al., 2013) and pcDNA-33K plas-
mids were constructed by inserting the synthetic IVa2 or 33K
gene cassette (codon- optimized for expression in mammalian
cells), respectively, into pcDNA3.1. The 33K gene cassette (either
for bacterial or mammalian cell expression) cannot express L4
22K protein (a shorter-version of 33K protein produced in
HAdV5-infected cells due to alternative splicing).
Expression and Purification of 6His-Tagged
33K and IVa2
For expression of 33K, pET28-33K transfected E. coli BL21 (DE3)
pLysS (EMD Biosciences) cells were grown to an optical den-
sity (OD) of 0.8 at 600 nm, and 33K expression was induced
for 4 h at 37◦C. The puriﬁcation was done using a His-bind
protein puriﬁcation kit (EMD Biosciences). Puriﬁed 33K was
dialyzed against 20mMTris pH 8.0, 400mMNaCl, and 10% glyc-
erol. Protein concentration was estimated by a Coomassie protein
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assay (Thermo Scientiﬁc, Rockford, IL, USA). Final yield of 33K
was ∼3 mg from 350 ml culture.
For expression of IVa2, E. coli BL21 (DE3) pLysS (EMD
Biosciences) cells containing pET28-IVa2 were grown to an
approximate 1.6 OD at 600 nm, and the expression was induced
for 16 h at 12◦C. Puriﬁcation was done by immobilized metal ion
aﬃnity chromatography with an ÄKTA Prime Plus System (GE
Healthcare, Piscataway, NJ, USA) at 4◦C using a HiTrap NiNTA
column (GE Healthcare). IVa2 containing fractions were pooled
and further puriﬁed at 4◦C using a HiPrep 16/10 SP-XL column
(GE Healthcare). After the previous step was completed, IVa2
containing fractions were again pooled, dialyzed against buﬀer
containing 50 mMTris, 500 mMNaCl, 5% glycerol, concentrated
to 1 mg ml−1 using 30 kDa cutoﬀ Amicon ultra-15 centrifugal
ﬁlter units (Millipore, Billeria, MA, USA), and stored at −80◦C
in aliquots. The ﬁnal yield of IVa2 was ∼5 mg from a 1000 ml
culture.
SDS–PAGE under Reducing and
non-Reducing Conditions
Puriﬁed proteins, puriﬁed virus, or cell extracts were treated with
reducing Laemmli buﬀer (50 mM Tris, pH 6.8, 10% glycerol, 2%
SDS, 5% beta-mercaptoethanol, and 0.02% bromophenol blue)
followed by boiling for 5 min, or non-reducing Laemmli buﬀer
(50 mM Tris, pH 6.8, 10% glycerol, 2% SDS, and 0.02% bro-
mophenol blue) and separated on SDS-PAGE. The gel was either
stained with Coomassie blue or processed for immunoblotting.
The immunoblotting was performed using polyclonal anti-IVa2
and anti-33K antibodies raised in rabbits against bacterially puri-
ﬁed IVa2 or 33K as described earlier (Ahi et al., 2013). 33K
shares its N-terminal 105 amino acids residues with another
HAdV5 protein, L4 22K, but our anti-33K antibody did not
react with L4 22K, which runs at ∼30K (Oosterom-Dragon
and Anderson, 1983; Ewing et al., 2007). Our anti-33K anti-
body detected only a single band at ∼35K, suggesting that
it did not react with L4 22K.
Transmission Electron Microscopy
Glow-discharged 400 mesh copper with carbon-coated form-
var grids (Electron Microscopy Sciences, Hatﬁeld, PA, USA)
were used for transmission electron microscopy (TEM) of puri-
ﬁed protein samples. The grids were ﬂoated on protein sam-
ple droplets for 1 min, rinsed with 20 mM Tris, pH 7.5 to
remove unbound proteins, and stained with 2% uranyl acetate.
Imaging was done with FEI/Philips CM-100 TEM (Philips/FEI
Corporation, Eindhoven, Netherlands). Images were captured at
92,000× and 180,000×.
Purification of the Terminal
Protein-Associated HAdV5 Genome
The terminal protein (Tp)-associated HAdV5 genome (Tp-DNA)
was isolated from puriﬁed HAdV5 as described (Graham and
Prevec, 1991). Brieﬂy, puriﬁed virus in TE buﬀer (10 mM Tris
and 1 mM EDTA, pH 8.0) was mixed with an equal volume
of 8 M guanidine hydrochloride in TE buﬀer and incubated
on ice for 30 min, mixing every 10 min. Cesium chloride and
guanidine chloride concentrations in the mixture was adjusted
to 2.8 M and 4 M, respectively. The solution was centrifuged at
55,000 rpm in the VTi65.1 rotor (Beckman Coulter, Indianapolis,
IN, USA) at 4◦C for 16 h. Fractions of 0.5 ml size were col-
lected and analyzed for the presence of Tp-DNA by agarose
gel electrophoresis. Fractions containing Tp-DNA were pooled
and dialyzed against TE buﬀer. The Tp-DNA concentration was
determined spectrophotometrically.
ATPase assay
The assay for determining ATPase activity of IVa2 was done
in the presence or absence of puriﬁed 33K and Tp-DNA. The
puriﬁed IVa2 in the absence or presence of equal amounts of
33K was dialyzed against buﬀer containing 50 mM Tris, pH
7.5, 400 mM NaCl, and 10% glycerol. ATPase reactions con-
tained 50 mM Tris, pH7.5, 100 mM NaCl, 10 mM MgCl2,
0.5 mM ATP, 1 μg protein/s (IVa2+33K, or IVa2, or 33K) with
or without 5 μg Tp-DNA in a 200 μl volume. Reactions were
incubated at 37◦C for 30 min. At end of the incubation, the inor-
ganic phosphate concentration in the reactions was measured
using ATPase Assay System (Innova Biosciences, Babraham,
Cambridge, UK).
Results
Oligomeric State of IVa2 and 33K in
Virus-Infected Cells, Purified Virus
Preparations and Transfected Cells
It has been shown that both IVa2 and 33K are located at a unique
vertex of the viral capsids (Christensen et al., 2008; Ahi et al.,
2013). We therefore proposed that IVa2 and 33K might assemble
into ring-like oligomers with a central channel large enough to
allow the passage of the viral genome. To this end, we analyzed
the oligomers of IVa2 and 33K in virus-infected cells. Lysates
of HAdV5-infected cells were processed for SDS–PAGE in both
reducing and non-reducing conditions, followed by a Western
blot with anti-IVa2 or anti-33K antibody. In reducing conditions,
IVa2 migrated at a molecular mass of 50 kDa as expected for
a monomer (Figure 1A). However, in non-reducing conditions,
IVa2 was detected at the molecular mass expected for monomers,
dimers and higher order oligomers (Figure 1A). The 33K was
detected as a monomer in both the reducing and non-reducing
conditions (Figure 1B).
Next, we analyzed the oligomers of IVa2 and 33K in puri-
ﬁed virus particles. Puriﬁed HAdV5 virions were analyzed by
SDS-PAGE in both reducing and non-reducing conditions and
Western blots with anti-IVa2 or anti-33K antibody. In reduc-
ing conditions, the anti-IVa2 antibody reacted with two bands
running close together with a proportionally lesser amount of
the smaller band indicated by an asterisk (Figure 2A – lane
with 10 μg protein in reducing condition). The smaller band
may represent an unmodiﬁed form of IVa2. Under non-reducing
conditions, a smear-like pattern was detected above 100 kDa, pos-
sibly reﬂecting dimers and multimers of IVa2 or its association
with other capsid proteins. The anti-33K antibody reacted with
a single band in reducing conditions, whereas in non-reducing
conditions, a clear band was detected at ∼70 kDa, the expected
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FIGURE 1 | Oligomeric state of IVa2 and 33K proteins in virus infected
cells. Mock or HAdV5 infected cell lysates were prepared at 36 h post-infection
and treated in reducing or non-reducing conditions. Twenty microgram cell
lysates were separated on SDS-PAGE, the proteins transferred to membrane
and analyzed by Western blots with anti-IVa2 (A) or anti-33K (B) antibodies.
Positions of monomer, dimer, and trimer of IVa2 are indicated. Molecular mass
markers are indicated on the left.+β-ME, beta-mercaptoethanol was used as a
reducing agent.
FIGURE 2 | Oligomeric state of IVa2 and 33K proteins in purified virus.
Indicated amounts of purified HAdV5 virus were treated in reducing or
non-reducing conditions and analyzed by Western blots with anti-IVa2 (A) or
anti-33K (B) antibodies. Positions of monomer and multimers of each protein
are indicated. Molecular mass markers are indicated on the left. +β-ME,
beta-mercaptoethanol was used as a reducing agent.
position for a dimer (Figure 2B). In addition, a smear-like pat-
tern appeared above 150 kDa reﬂecting higher oligomers of 33K
or its association with other capsid proteins. A small fraction of
33K was also detected at the monomer position.
We next sought to evaluate the IVa2 and 33K oligomers in
the absence of other viral factors to ascertain whether the pres-
ence of 33K inﬂuences the oligomer formation by IVa2 and vice
versa. These experiments involved transient transfections in 293,
293-IVa2, and 293-33K cells. To study IVa2 oligomers in both the
absence and presence of 33K, the 293, or 293-33K cells were trans-
fected with pcDNA-IVa2 and processed for Western blot with
anti-IVa2 or anti-33K antibody. IVa2 oligomers were detected
in the 293 cells transfected with pcDNA-IVa2 (293 + IVa2) in
non-reducing conditions (Figure 3A). A far greater amount of
IVa2 oligomers was detected when 33K was also present (com-
pare 293 + IVa2 and 293-33K + IVa2), suggesting that 33K
promotes oligomer formation by IVa2. Similarly, muchmore 33K
oligomers were detected when IVa2 was also present (compare
293 + 33K and 293-IVa2 + 33K), suggesting that IVa2 also pro-
motes oligomer formation by 33K (Figure 3B). It is noteworthy
that both IVa2 and 33K oligomers do not seem to form in sig-
niﬁcant amounts when expressed individually in their respective
stable cell lines. This could be due to a lower amount of protein
being expressed in stable cell lines (293-IVa2 and 293-33K) as
compared to transient transfections (293+ IVa2 and 293+ 33K).
However, the detected level is suﬃcient to promote the oligomer
formation of its ‘interacting partner’ expressed at a higher level in
transient transfection.
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FIGURE 3 | Oligomeric state of IVa2 and 33K proteins in transfected
cells. (A) Mock or pcDNA-IVa2 transfected 293 or 293-33K cells were
harvested at 36 h post-transfection and treated with (+) or without (−)
beta-mercaptoethanol (β-ME). 293-IVa2 cells were used as controls. (B) Mock
or pcDNA-33K transfected 293 or 293-IVa2 cells were harvested at 36 h
post-transfection and treated in reducing or non-reducing conditions.
293-33K cells were used as controls. Cell lysates were analyzed by Western
blots with anti-IVa2 (A) or anti-33K (B) antibody. Similar results were obtained
in four independent transfection studies. For monitoring equal loading, the
Western blots for beta-actin were conducted and shown as an insert at the
bottom of each blot. Positions of monomer and higher order multimers are
indicated. Molecular mass markers are indicated on the left. In the figure, 293
cells transfected with pcDNA-IVa2 are denoted as 293 + IVa2; 293 cells
stably expressing IVa2 are denoted as 293-IVa2; 293 cells transfected with
pcDNA-33K are denoted as 293 + 33K; 293 cells stably expressing 33K are
denoted as 293-33K.
Expression and Purification of IVa2 and 33K
In order to characterize the oligomeric state of IVa2 and 33K
in the absence of other proteins, IVa2 and 33K were expressed
in bacteria and puriﬁed. Puriﬁed 33K (Figure 4A) migrated as
a single band at the molecular mass of approximately 35 kDa.
Earlier studies had reported a similar migration pattern of 33K
(Oosterom-Dragon and Anderson, 1983).
The IVa2 was found in both soluble and insoluble fractions
(Figure 4B). The puriﬁed preparation contained a major species,
indicated by an arrow, migrating at a molecular mass of 53 kDa
(Figure 4C) as expected for IVa2. The identity of this band was
conﬁrmed by Western blot (data not shown). In addition, an
impurity (asterisk) migrating at ∼60 kDa was also found that did
not react with anti-IVa2 antibody (data not shown). The impurity
was removed using a HiPrep 16/10 Sp XL cation exchange col-
umn (Figure 4C). Identities of the puriﬁed IVa2 and 33K proteins
were conﬁrmed by mass spectrometric analysis (data not shown).
Oligomeric State of Purified IVa2 and 33K
Proteins
The puriﬁed IVa2 and 33K proteins were subjected to SDS–
PAGE in both reducing and non-reducing conditions followed
by Coomassie staining or Western blot. In reducing conditions,
both IVa2 (Figures 5A,B) and 33K (Figures 5C,D) migrated
as monomers at the molecular mass of approximately 53 and
35 kDa, respectively. In addition to the full-length IVa2 band, a
faster migrating band was detected by anti-IVa2 antibody, sug-
gesting that it may be a degradation product of IVa2 (Figure 5B).
In non-reducing conditions, IVa2 appeared as a series of bands
corresponding to the molecular mass of dimers and higher order
multimers. Similar results were obtained byWestern blot with an
anti-IVa2. Similarly, in non-reducing conditions, 33K was found
in dimers and higher order multimers, but a signiﬁcant fraction
was also present as a monomer (Figure 5C). Similar results were
obtained by Western blot with anti-33K antibody (Figure 5D).
In order to determine the structural features of these
oligomers, the puriﬁed proteins were analyzed by TEM. IVa2
was found to be distributed in two populations: large rings
(Figure 6A; arrow) and smaller structure (Figure 6A; arrow
head) populations (Figure 6A). The smaller structures were
roughly of 7–9 nm in diameter. The larger rings were more vari-
able in size ranging from 30 to 50 nm in diameter. Puriﬁed
33K was found in rings of approximately 15–17 nm in diame-
ter (Figure 6B) forming a cone-like structure (Inset, Figure 6B;
arrowhead).
IVa2 and 33K Associate with HAdV5
Packaging Domain
The association of IVa2 with the AdV PD (Ostapchuk et al.,
2005) and with 33K (Ahi et al., 2013) during virus infec-
tion has already been demonstrated. To determine whether
33K associates with the AdV PD in virus-infected cells,
a DNA-protein pull down assay was performed using a
5′biotin-labeled AdV PD and virus-infected cell extract as
described earlier (Wu, 2006). The HAdV5 PD sequence, between
nucleotides 191–360, was labeled with biotin at both ends
using 5′ biotin-labeled forward and reverse primers for PCR
ampliﬁcation.
The rationale of using ADLC8cluc-infected 293cre cells was
based on the fact that the PD of ADLC8cluc is ﬂanked by loxP
sites and therefore, will be removed by the loxP-cre recom-
binase system and, thus, ensure an abundance of free IVa2
and 33K for an in vitro binding assay. Nuclear extracts of
ADLC8cluc-infected 293cre cells were incubated with a 5′biotin-
labeled AdV PD, followed by puriﬁcation of DNA-protein com-
plexes using streptavidin agarose beads. The puriﬁed com-
plexes were analyzed by Western blots using anti-IVa2 or anti-
33K antibody. Both IVa2 and 33K were present in the puri-
ﬁed complexes with the biotin-labeled PD (Figure 7A), but
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FIGURE 4 | Expression and purification of 33K and IVa2.
(A) Expression and purification of 33K: whole cell extracts of un-induced
culture, induced culture and 5 μg purified protein were processed for
SDS-PAGE and the gel was stained with Coomassie blue. (B) Expression
of IVa2 in soluble form: insoluble and soluble fractions of un-induced
cultures or cultures induced for 16 or 24 h at 12◦C were separated on
SDS-PAGE gel, and the gel was stained with Coomassie blue.
(C) Purification of IVa2 expressed in the soluble fraction: IVa2 was
purified, first by NiNTA affinity chromatography, and then by Ion exchange
chromatography. Samples from various stages of purifications were
collected and analyzed SDS-PAGE gel and Coomassie blue staining. FT,
flow through.
were not found in the absence of a 5′biotin-labeled AdV PD
or in the presence of a non-speciﬁc DNA (not shown). This
result indicates that IVa2 and 33K interact with the AdV PD
in vitro.
33K Stimulates ATPase Activity of IVa2 in the
Presence of Viral Genome
IVa2 is thought to act as an ATPase during genome packag-
ing; however, its ATPase activity has not been demonstrated yet.
Given that IVa2 interacts with 33K, we hypothesized that 33K
is required for activation of ATPase activity of IVa2. In order
to test this, puriﬁed IVa2 was dialyzed in both the absence and
presence of puriﬁed 33K against 33K dialysis buﬀer (50 mM Tris
pH 7.5, 400 mM NaCl, and 10% glycerol) with an intention to
form complexes between the two proteins. Protein concentration
of the resulting mixture was determined by a Coomassie protein
assay. The dialyzed mixture was incubated in an ATPase reac-
tion mixture in the presence or absence of Tp-DNA (HAdV5
genome complexed with TPs). Reactions were incubated at 37◦C
for 30 min, and the concentration of inorganic phosphate in
each reaction was measured using the Innova Biosciences ATPase
assay system. A statistically signiﬁcant (P < 0.05) increase in
the Pi concentration was observed in reactions containing all
three components – IVa2, 33K, and the Tp-DNA. However,
no signiﬁcant increase was observed in reactions that con-
tained only IVa2 + 33K, 33K + Tp-DNA, or IVa2 + Tp-
DNA (Figure 7B). Given that the Pi concentration in reactions
when any one of the three components was omitted was sim-
ilar to that of buﬀer alone and that there was only a threefold
increase in Pi concentration when all three components were
present suggests that other components are required for maxi-
mal ATPase activity. Nevertheless, this result does suggest that
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FIGURE 5 | Oligomeric state of purified IVa2 and 33K proteins. Indicated
amounts of purified IVa2 (A,B) or 33K (C,D) proteins were treated in reducing or
non-reducing conditions and separated on SDS-PAGE gel. Gel was either
processed for Coomassie blue staining (A,C) or processed for Western blots
with anti-IVa2 (B) or anti-33K (D) antibodies. Positions of monomer, dimer, or
higher multimers of each protein are indicated.
FIGURE 6 | Transmission electron microscopy (TEM) of purified IVa2 and 33K proteins. Purified proteins were applied to grids and imaged with TEM.
(A) IVa2 (180,000×). (B) 33K (90,000×). Inset to (B): individual 33K particles at 250K magnification.
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FIGURE 7 | (A) Binding of IVa2 and 33K to the packaging domain (PD):
Nuclear extracts of ADLC8cluc infected 293cre cells were treated with
5′-biotin labeled HAdV5 packaging signal sequences and the DNA protein
complexes were purified using streptavidin agarose beads. Purified proteins
were analyzed by Western blots with anti-IVa2 or anti-33K antibodies.
Positions of IVa2 and 33K bands are indicated. (B) ATPase activity of IVa2 in
the presence of 33K and the HAdV5 genome: ATPase assay was performed
with purified IVa2 in the presence of 33K, or HAdV5 Tp-DNA or both.
Concentration of inorganic phosphate (Pi), indicated on the Y-axis, in
reactions at end of reaction incubation is indicated on y axis. *P < 0.05. The
error bar represents SD.
33K stimulates ATPase activity of IVa2 in the presence of viral
genome.
Discussion
Adenoviruses are presumed to package their genome into pre-
assembled empty capsids via a mechanism similar to bacte-
riophages and herpesviruses. AdV assembly continues along a
pathway that proceeds through the assembly of the hexons and
pentons, the assembly of empty capsids, and the speciﬁc recog-
nition of the PD followed by packaging of the viral genome by
the packaging machinery into empty capsids. This is followed
by the proteolytic cleavage of precursor proteins by a viral pro-
tease leading to the ﬁnal maturation of viral particles. IVa2 is
believed to function as an equivalent to the DNA packaging
ATPases in bacteriophages and herpesviruses. The 33K protein
also has been reported to be essential for capsid assembly and
genome packaging (Wu et al., 2013). In an attempt to further
characterize the roles of IVa2 and 33K in capsid assembly and
genome packaging, we analyzed the oligomer status of IVa2 and
33K in virus-infected cells, puriﬁed virus, IVa2, and 33K trans-
fected cells and bacterial-expressed proteins. We showed that
both IVa2 and 33K form oligomers and enhance oligomer for-
mation by each other to provide the ﬁrst evidence of the ATPase
activity of IVa2.
Disulﬁde linkages have been shown to be necessary for the
formation of the portal ring by the portal protein UL6 and also
for the assembly of procapsids compatible with HSV-1 packaging
(Albright et al., 2011). In our experiments, detection of slower
migrating bands in non-reducing conditions in virus-infected
cells and puriﬁed virus extracts with anti-IVa2 antibody suggest
that IVa2 forms oligomers and that the oligomers are stabilized
by disulﬁde linkages. Since the cell lysates and puriﬁed virus were
treated with Laemmli buﬀer containing 2% SDS, it is unlikely that
the observed oligomers are due to non-covalent interactions. The
presence of a substantial amount of IVa2 as a monomer in the
virus-infected cells and puriﬁed virus extracts in non-reducing
conditions indicates that not all IVa2 subunits are stabilized by
the disulﬁde linkages.
Similar to IVa2, 33K also appeared to form dimer and higher
oligomers in the puriﬁed virus extract. Surprisingly, the dimer
and higher oligomers of 33K were not observed in virus-infected
cells. Since 33K is a multifunctional protein, involved in late pro-
tein transcription, capsid assembly as well as genome packaging
(Ali et al., 2007; Wu et al., 2013), it is likely that, in virus-
infected cells, it remains as a monomer before being associated
with virions. It is also possible that the relative amount of virion-
associated 33K in virus-infected cells is very low compared to
its free fraction. Oligomers, along with some monomer, were
also observed in puriﬁed IVa2 and 33K in non-reducing condi-
tions (Figure 5). In addition, oligomers of both IVa2 and 33K
were observed in transfected cells. The presence of IVa2 and 33K
seems to drastically enhance oligomer formation by 33K and
IVa2, respectively, suggesting a functional interaction of these
proteins.
TEM analysis of puriﬁed IVa2 did not reveal large aggre-
gates even at a high concentration of 2 mg ml−1. This sug-
gests that the protein is soluble, and oligomers detected by
SDS–PAGE are not due to improper folding or non-speciﬁc
aggregation. The structures of IVa2 observed by TEM can
be classiﬁed into two types: small structures with a diame-
ter of ∼7–9 nm and larger “rings” with a diameter between
30 and 50 nm. The diameter of a globular protein of 50 kDa
is expected to be 4–5 nm (Kiselyova and Yaminsky, 2004),
suggesting that the small structures may be dimers. IVa2 was
shown to be present at a unique vertex and has only 6–
8 copies per capsid (Christensen et al., 2008). It is likely
that the basic unit of the IVa2 oligomer at a unique ver-
tex is a dimer similar to the smaller structures observed by
TEM. Large terminases of all dsDNA phages including T4, T7,
SPP1, and P22 (Nemecek et al., 2007; Rao and Feiss, 2008)
are known to exist as monomers in solution, but, in pack-
aging, the ATPase gp16 of ph29 forms trimers and ring-like
oligomers with a ∼9.5 nm diameter at concentrations between
0.2 and 0.8 mg ml−1 (Koti et al., 2008). Our preliminary TEM
studies of puriﬁed 33K indicate that it organizes into ring-
like structures with a diameter of ∼17 nm. Further analyses
of IVa2 and 33K at a higher resolution will be required to
determine their structural features.
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FIGURE 8 | Diagrammatic representation of the role of IVa2 and 33K in
AdV genome packaging. Empty virions are assembled from the major capsid
proteins with the help of the portal protein (unknown), scaffolding protein
(unknown), and core proteins. The AdV genome is recognized by the packaging
proteins IVa2 and 33K (other packaging proteins are not shown for the sake of
simplicity) due to the presence of the PD near the left end of the genome. In
association with 33K, the ATPase activity of IVa2 propels the viral genome into
an empty virion particle through the portal. It is anticipated that the portal protein
will interact with IVa2. Upon completion of packaging, the 33K protein and
scaffolding proteins are released. Some core proteins may encapsidate during
and/or after the genome packaging and undergo maturation. Finally, a fiber
molecule is assembled at the portal vertex.
It appears that IVa2 serves as the packaging ATPase. The
absence of 33K in mature AdV (Ahi et al., 2013) indicates that
33K does not serve as a portal. In addition to the portal and pack-
aging ATPase, the third component of the packaging motor is a
small terminase which also forms ring-like oligomers. Analysis of
the oligomeric state of the puriﬁed small terminase gp16 of T4
and related phages which yield a ladder of bands suggest the exis-
tence of these proteins as larger oligomers (Leﬀers and Rao, 2000;
Koti et al., 2008; Gao and Rao, 2011). Puriﬁed gp16 is shown to
form rings of ∼8 nm diameter with a central hole of ∼2 nm (Lin
et al., 1997). The ring-like oligomers of the small terminase of a
T4-like phage assemble with 8–12 subunits and appear to have a
cone-like structure (Sun et al., 2012). The small terminase gp3 of
phage P22 forms a ring-like structure of ∼9 nm in diameter with
a central hole and outwardly projecting spikes (Nemecek et al.,
2007). In the case of phage SPP1, the two or three ring-shaped
decamers of g1p interact with g2p and assemble at a unique vertex
(Camacho et al., 2003).
The small terminase protein enhances the ATPase activity of
the larger terminase which, by itself, is a weak ATPase (Leﬀers
and Rao, 2000; Camacho et al., 2003; Rao and Feiss, 2008). IVa2
is thought to be the packaging ATPase of AdV equivalent to the
large terminase of phage. It should be noted that IVa2 does not
have terminase activity as such activity is not needed for AdV
replication. We recently demonstrated that 33K interacts with
IVa2 and extensively co-localizes in the absence of other viral pro-
teins (Ahi et al., 2013). Additionally, our results suggest that IVa2
and 33K promote oligomer formation by each other implying
interaction with 33Kmay be required for ATPase activity of IVa2.
Along the same line, the ATPase activity of IVa2 was detected
in the presence of 33K and the viral genome. However, only a
low level of ATPase activity was detected which may be partly
due to several factors: improper folding, lack of post-translation
modiﬁcations of IVa2 and 33K when expressed in bacteria, or
the absence of other important components. The characteriza-
tion of the ATPase function of IVa2 is very preliminary at this
stage, but it certainly has provided a platform for future exper-
iments to determine the optimal conditions for ATPase activity.
Additionally, the necessity of other components such as a portal,
other interacting partner/s, or the procapsid should be systemati-
cally examined to determine the optimum conditions for ATPase
function of IVa2.
Several lines of evidence indicate that 33K is the small ter-
minase for AdV. 33K is present in empty but not in mature
capsids, is located at a unique site on the capsid, and interacts
with the large terminase equivalent of IVa2 (Ahi et al., 2013). In
addition, the results presented in this manuscript elucidate the
formation of ring-like oligomers of 33K and its stimulation of
IVa2 ATPase activity. The role of IVa2 and 33K in the AdV pack-
aging is depicted in a diagrammatic form (Figure 8). A BAdV3
mutant carrying a stop codon at position 7 in the ORF of the 33K
showed signiﬁcant reduction in mature particles compared to the
wild type BAdV3, suggesting a defect in the process of genome
packaging (Kulshreshtha et al., 2004). Similarly, introduction of a
stop codon at position 20 in the ORF of 33K in HAdV5 decreased
virus yield (Fessler and Young, 1999). These observations suggest
that, analogous to the small terminase protein, the 33K plays an
important role in genome packaging. Another mutant of BAdV3
carrying a stop codon at position 97 in the ORF of the 33K
failed to assemble virus particles, pointing toward a role of 33K
in capsid assembly (Kulshreshtha et al., 2004). Along the same
line of thought, deletion of the C-terminal 47 amino acids of
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33K of HAdV5 completely abolished capsid assembly (Finnen
et al., 2001). Taken together, these results imply that a
domain in the C-terminus of 33K is required for capsid
assembly, whereas, the function of 33K in genome packag-
ing is located in its N-terminus. Thus, the 33K seems to
play important roles in both capsid assembly and genome
packaging.
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